Second quarter 2021 sales from continuing operations increased by 12% in local currency to CHF 1.032 billion
Underlying EBITDA of €602 million in Q2 2021 was up +47% year on year on a comparable scope and foreign exchange basis, reflecting strong demand and continued cost reductions
The company posted net profit f Rs.85.45 crores for the period ended June 30, 2020.
The company posted net profit of Rs.111.44 crores for the period ended June 30, 2020.
The company reported total income Rs.18.57 crores during the period ended June 30, 2020.
The company posted net profit of Rs.321 crores for the period ended June 30, 2020.
The company has posted net loss of Rs.(14.02) crores for the period ended June 30, 2020.
The company posted net profit of Rs.594.6 crores for the period ended June 30, 2020.
The company posted net profit of Rs.19.36 crores for the period ended June 30, 2020.
Additionally, the company has filed 1,026 applications for registrations globally pending at different stages
The contribution of Wockhardt at Wrexham is one of the best examples of the success and significant potential of India-UK partnerships in the healthcare sector
The first six batches are being shipped to the Gamaleya Center, Moscow for the quality approval
The unadjusted data show a 0.1% advance in July, a slowdown from a 0.3% rise in June and 1.0% gain in May.
R&D partnership will give farmers more options for fighting weeds worldwide
The transaction is expected to close in the fourth quarter of 2021 subject to regulatory approvals and other customary closing conditions.
Next Beauty has launched more than 15 successful brands in China in less than three years
The Cephalosporin Injectables plant has a total capacity of 26.4 million vials per year while Ethiopia is having a demand for 16 million vials
Winlevi has been approved by the United States FDA as a novel drug with a unique mechanism of action for the topical treatment of acne in patients 12 years and older
The company posted net loss of Rs.56.69 crores for the period ended June 30, 2020.
The company has decided to transfer our rights in relation to the lodex and Ostocalcium brands to GlaxoSmithKline Asia Private Limited
TotalEnergies - Gurin Energy selects Saft’s battery energy storage system for first Japanese project
Subscribe To Our Newsletter & Stay Updated
